Literature DB >> 30060276

[Diagnosis and Therapy of Immune thrombocytopenia].

Axel Matzdorff1, Bernhard Wörmann2.   

Abstract

Immune thrombocytopenia (ITP) is a heterogeneous disease. Diagnosis of primary ITP continues to be based on the exclusion of all known causes for secondary ITP. The new ITP classification distinguishes three categories. First line treatment consists of either dexamethasone or prednisone. The most effective options in second line treatment are splenectomy or thrombopoietin receptor agonists. The medical societies for hematology and oncology of the German-speaking countries have recently updated their guidelines on ITP. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30060276     DOI: 10.1055/a-0384-4703

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  2 in total

1.  Positivity rate of systematic bone marrow smear in patients over 60 years old with newly diagnosed immune thrombocytopenia.

Authors:  Thibault Comont; Johanne Germain; Odile Beyne-Rauzy; Daniel Adoue; Guillaume Moulis
Journal:  Blood Adv       Date:  2020-05-26

2.  Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia.

Authors:  Qian Wang; Juan Li; Tian-Shu Yu; Yu Liu; Kai Li; Shuang Liu; Yang Liu; Qi Feng; Lei Zhang; Guo-Sheng Li; Lin-Lin Shao; Jun Peng; Ming Hou; Xin-Guang Liu
Journal:  Int J Biol Sci       Date:  2019-10-23       Impact factor: 6.580

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.